Canada markets close in 4 hours 45 minutes

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1350-0.0050 (-0.44%)
As of 11:15AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
116,882
116,882
120,242
149,236
108,621
Cost of Revenue
7,110
7,110
1,749
1,083
895
Gross Profit
109,772
109,772
118,493
148,153
107,726
Operating Expenses
Research Development
24,522
24,522
60,272
65,237
60,101
Selling General and Administrative
105,741
105,741
112,451
91,891
76,598
Total Operating Expenses
130,263
130,263
172,723
157,128
136,699
Operating Income or Loss
-20,491
-20,491
-54,230
-8,975
-28,973
Interest Expense
6,872
6,872
3,707
4,860
1,353
Total Other Income/Expenses Net
-
-
-1,320
-3,521
-
Income Before Tax
-25,091
-25,091
-58,573
-17,309
-29,744
Income Tax Expense
0
0
0
605
0
Income from Continuing Operations
-25,091
-25,091
-58,573
-17,914
-29,744
Net Income
-25,091
-25,091
-58,573
-17,914
-29,744
Net Income available to common shareholders
-25,091
-25,091
-58,573
-17,914
-29,744
Basic EPS
-0.14
-
-0.34
-0.11
-0.18
Diluted EPS
-0.14
-
-0.34
-0.11
-0.18
Basic Average Shares
173,637
-
172,406
170,492
168,754
Diluted Average Shares
173,637
-
172,406
170,492
168,754